Cardiac dysfunction and cell damage across clinical stages of severity in growth-restricted fetuses

American Journal of Obstetrics and Gynecology

Volumn 199, Issue 3, 2008, Pages 254.e1-254.e8

  Crispi, Fatima ^a,b   Hernandez Andrade, Edgar ^a   Pelsers, Maurice M A L ^c   Plasencia, Walter ^e   Benavides Serralde, Jesus Andres ^a   Eixarch, Elisenda ^a   Le Noble, Ferdinand ^f   Ahmed, Asif ^b   Glatz, Jan F C ^d   Nicolaides, Kypros H ^e   Gratacos, Eduard ^a  

^a Institut Clínic de Ginecologia   (Spain)

^b UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

cardiac function; Doppler ultrasound; heart fatty acid binding protein; intrauterine growth restriction; myocardial damage

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; FATTY ACID BINDING PROTEIN; TROPONIN I;

ARTICLE; BLOOD FLOW; CELL DAMAGE; CONTROLLED STUDY; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; FEMALE; FETUS; GESTATIONAL AGE; HEART DISEASE; HEART FUNCTION; HEART MUSCLE CELL; HEART OUTPUT; HEART PERFORMANCE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

EID: 50649114648     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2008.06.056     Document Type: Article

References (37)

1. Alberry M., and Soothill P. Management of fetal growth restriction. Arch Dis Child Fetal Neonatal Ed 92 (2007) 62-67
2. Hecher K., Campbell S., Doyle P., Harrington K., and Nicolaides K. Assessment of fetal compromise by Doppler ultrasound investigation of the fetal circulation: arterial, intracardiac, and venous blood flow velocity studies. Circulation 91 (1995) 129-138
3. Makikallio K., Vuolteenaho O., Jouppila P., and Rasanen J. Ultrasonographic and biochemical markers of human fetal cardiac dysfunction in placental insufficiency. Circulation 105 (2002) 2058-2063
4. Figueras F., Puerto B., Martinez J.M., Cararach V., and Vanrell J.A. Cardiac function monitoring of fetuses with growth restriction. Eur J Obstet Gynecol Reprod Biol 110 (2003) 159-163
5. Niewiadomska-Jarosik K., Lipecka-Kidawska E., Kowalska-Koprek U., et al. Assessment of cardiac function in fetuses with intrauterine growth retardation using the Tei index. Med Wieku Rozwoj 9 (2005) 153-160
6. Girsen A., Ala-Kopsala M., Makikallio K., Vuolteenaho O., and Rasanen J. Cardiovascular hemodynamics and umbilical artery N-terminal peptide of proB-type natriuretic peptide in human fetuses with growth restriction. Ultrasound Obstet Gynecol 29 (2007) 296-303
7. Baschat A.A., and Harman C.R. Venous Doppler in the assessment of fetal cardiovascular status. Curr Opin Obstet Gynecol 18 (2006) 156-163
8. Barker D.J., Osmond C., Golding J., Kuh D., and Wadsworth M. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ 298 (1989) 564-567
9. Vuguin P.M. Animal models for small for gestational age and fetal programming of adult disease. Horm Res 68 (2007) 113-123
10. Baschat A.A., Cosmi E., Bilardo C.M., et al. Predictors of neonatal outcome in early-onset placental dysfunction. Obstet Gynecol 109 (2007) 253-261
11. Chaiworapongsa T., Espinoza J., Yoshimatsu J., et al. Subclinical myocardial injury in small-for-gestational-age neonates. J Matern Fetal Neonatal Med 11 (2002) 385-390
12. Iacovidou N., Boutsikou M., Gourgiotis D., et al. Perinatal changes of cardiac troponin-I in normal and intrauterine growth restricted pregnancies. Mediators Inflamm 2007 (2007) 53921
13. Setsuta K., Seino Y., Ogawa T., Arao M., Miyatake Y., and Takano T. Use of cytosolic and myofibril markers in the detection of ongoing myocardial damage in patients with chronic heart failure. Am J Med 113 (2002) 717-722
14. Pelsers M., Hermens W.T., and Glatz J.F.C. Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta 352 (2005) 15-35
15. Glatz J.F.C., Van der Putten R.F.M., and Hermens V.V.T. Fatty acid-binding protein as an early plasma marker of myocardial ischemia and risk stratification. In: Wu A.H.B. (Ed). Cardiac markers. 2nd ed. (2003), Humana Press, Totowa (NJ) 319-337
16. Danesh J., Wheeler J.G., Hirschfield G.M., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350 (2004) 1387-1397
17. Pepys M.B., and Hischfield G.M. C-reactive protein: a critical update. J Clin Invest 111 (2003) 1805-1812
18. Figueras F., Meler E., Iraola A., et al. Customized birthweight standards for a Spanish population. Eur J Obstet Gynecol (2007) Epub ahead of print
19. Baschat A.A., and Gembruch U. The cerebroplacental Doppler ratio revisited. Ultrasound Obstet Gynecol 21 (2003) 124-127
20. Bancalari E., and Claure N. Definitions and diagnostic criteria for bronchopulmonary dysplasia. Semin Perinatol 30 (2006) 164-170
21. Hernandez-Andrade E., Lopez-Tenorio, Figueroa-Diesel H., et al. A modified myocardial performance (Tei) index base on the use of valve clicks improves reproducibility of fetal left cardiac function assessment. Ultrasound Obstet Gynecol 26 (2005) 227-232
22. DeVore G.R. Assessing fetal cardiac ventricular function. Semin Fetal Neonatal Med 10 (2005) 515-541
23. Kiserud T., Ebbing C., Kessler J., and Rasmussen S. Fetal cardiac output, distribution to the placenta and impact of placental compromise. Ultrasound Obstet Gynecol 28 (2006) 126-136
24. Hecher K., Campbell S., Snijders R., and Nicolaides K. Reference ranges for fetal venous and atrioventricular blood flow parameters. Ultrasound Obstet Gynecol 4 (1994) 390-391
25. Hernandez-Andrade E., Figueroa-Diesel H., Kottman C., et al. Gestational-age-adjusted reference values for the modified myocardial performance index for evaluation of fetal left cardiac function. Ultrasound Obstet Gynecol 29 (2007) 321-325
26. Belenky A., Smith A., Zhang B., et al. The effect of class-specific protease inhibitors on the stabilization of B-type natriuretic peptide in human plasma. Clin Chim Acta 340 (2004) 163-172
27. Wodzig K.W., Pelsers M.M., van der Vusse G.J., Roos W., and Glatz J.F. One-step enzyme linked immunosorbent assay (ELISA) for plasma fatty acid-binding protein. Ann Clin Biochem 34 (1997) 263-268
28. Cuzick J. A Wilcoxon-type test for trend. Stat Med 4 (1985) 87-90
29. Tsutsumi T., Ishii M., Eto G., Hota M., and Kato H. Serial evaluation for myocardial performance index in fetuses and neonates using a new Doppler index. Pediatr Int 41 (1999) 722-727
30. Mahle W.T., Rychik J., Tian Z.Y., et al. Echocardiographic evaluation of the fetus with congenital cystic adenomatoid malformation. Ultrasound Obstet Gynecol 16 (2000) 620-624
31. Rizzo G., Arduini D., Romanini C., and Mancuso S. Doppler echocardiographic assessment of atrioventricular velocity waveforms in normal and small-for-gestational-age fetuses. BJOG 95 (1988) 65-69
32. Doust J.A., Pietrzak E., Dobson A.J., and Glasziou P.P. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 330 (2005) 625-639
33. Leipala J.A., Boldt T., Turpeinen U., Vuolteenaho O., and Fellman V. Cardiac hypertrophy and altered hemodynamic adaptation in growth-restricted preterm infants. Pediatr Res 53 (2003) 989-993
34. Trevisanuto D., Doglioni N., Altinier S., Zaninotto M., Plebani M., and Zanardo V. High-sensitivity C-reactive protein in umbilical cord of small-for-gestational-age neonates. Neonatology 91 (2007) 186-189
35. Biron-Shental T., Schaiff W.T., Ratajczak C.K., Bildirici I., Nelson D.M., and Sadovsky Y. Hypoxia regulates the expression of fatty acid-binding proteins in primary term human trophoblasts. Am J Obstet Gynecol 197 (2007) 516.e1-516.e6
36. Turan S., Turan O.M., Berg C., et al. Computerized fetal heart rate analysis, Doppler ultrasound and biophysical profile score in the prediction of acid-base status of growth-restricted fetuses. Ultrasound Obstet Gynecol 30 (2007) 750-756
37. Crispi F., Hernandez-Andrade E., Benavides-Serralde J.A., Padilla N., Acosta R., and Gratacos E. The use of a cardiac profile improves detection of heart dysfunction and prediction of poor perinatal outcome as compared with ductus venosus alone. Ultrasound Obstet Gynecol 30 (2007) 525